share_log

HC Wainwright & Co. Reiterates Buy on Novavax, Maintains $35 Price Target

Benzinga ·  Aug 10, 2023 07:43

HC Wainwright & Co. analyst Vernon Bernardino reiterates Novavax (NASDAQ:NVAX) with a Buy and maintains $35 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment